Company intelligence / Profile preview

Orpharm

Dmitrov, Russian Federation

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Orpharm acts as a full-service distributor and commercialization partner for rare and orphan drugs, as well as oncology therapeutics, focusing on the Russian and CIS markets. It operates as a regional partner in the World Orphan Drug Alliance, facilitating market access and patient reach for innovative therapies in these regions.[1][3][4][5]

Therapeutic areas: OncologyRare Diseases
Industry: Consulting

Partnerships

World Orphan Drug AllianceEffRx PharmaceuticalsMedisOrphanDCVector Pharma

Beyond the preview

Go deeper on Orpharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orpharm.

Explore the full profile